New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
A classic reinvents itself: InnuPure®C16 touch combines highly precise liquid handling with automated extraction
Learn about the essential multi-application centrifuge technology helping dermatology research
Niguarda Hospital, Milan, shares experiences in newly available case study
Project that measured pathogens in New York City subways goes global this summer
Watch interviews from industry experts at this year’s American Association of Cancer Research (AACR) Annual Meeting
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Company now selling directly to customers in South Korea
Offer safe, inexpensive way of visualizing a wide range of fluorescent gels
Studies demonstrate pioneering research possible using ChIP technology
Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services
Chromatrap® has announced a new 96-well high throughput purification plate for production of ultra-pure DNA
Download our new guide and learn how you can optimize your NGS workflow
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
What scientists really think